ICD-10 Code M16.2: Bilateral osteoarthritis from hip dysplasia

Key takeaways

ICD-10 Code M16.2 identifies bilateral osteoarthritis of the hip caused specifically by hip dysplasia, not primary idiopathic OA.

M16.2 is billable and specific for FY2026, effective October 1, 2025, under the ICD-10-CM tabular list maintained by CMS and NCHS.

Physicians must explicitly document hip dysplasia as the etiology. Coders cannot infer dysplastic cause from imaging alone when assigning M16.2.

Practice management software like Pabau links M16.2 directly to procedure codes at claim submission, reducing denials from mismatched diagnosis-procedure pairs.

Hip osteoarthritis claims are denied more often than coders expect, and the root cause is usually one missing word in the physician’s note: dysplasia. Without it, M16.0 is the safer call.

With it, ICD-10 Code M16.2 is the only correct code and the one that unlocks downstream surgical billing. This reference covers the clinical criteria, documentation rules, code differentiation, and CPT crosswalk that coders and clinicians need to assign M16.2 accurately for FY2026.

The distinction matters for reimbursement. Practices billing total hip arthroplasty paired with M16.0 risk claim rejection or audit flags. This happens when the chart documents a history of developmental dysplasia of the hip (DDH), for which ICD-10 Code M16.2 is the specific answer.

ICD-10 Code M16.2: Definition and billability

ICD-10 Code M16.2 is a billable, specific ICD-10-CM diagnosis code representing bilateral osteoarthritis resulting from hip dysplasia. The code became effective on October 1, 2025 for the FY2026 code year, as confirmed by the CMS ICD-10-CM annual update.

Because it is specific and billable, it can be submitted directly on a claim without additional subcode expansion. The full descriptor is: Bilateral osteoarthritis resulting from hip dysplasia. The WHO equivalent term is Coxarthrosis resulting from dysplasia, bilateral, per the WHO ICD-10 browser.

Clinical criteria for assigning M16.2

Two conditions must be satisfied before ICD-10 Code M16.2 can be assigned. The first is confirmed bilateral osteoarthritis of the hip. The second, easy to overlook, is documented evidence that hip dysplasia caused the OA. This makes M16.2 a secondary OA code: the arthritis is a consequence of an underlying structural abnormality.

• Confirmed bilateral hip OA: Imaging or clinical examination must establish osteoarthritic changes in both hips.
• Documented dysplastic etiology: The treating physician must explicitly state that hip dysplasia (developmental dysplasia of the hip, DDH, or congenital hip dysplasia) is the cause. Coders cannot infer etiology from imaging alone.
• Laterality satisfied: M16.2 covers bilateral involvement only. Unilateral dysplasia-related OA maps to M16.3.
• Secondary OA confirmed: The dysplastic anatomy (shallow acetabulum, abnormal femoral head coverage) must be the structural mechanism driving joint degeneration.

According to the CDC/NCHS ICD-10-CM official tool, the M16 category is used for coxarthrosis across all etiologies. The subcategory distinction, primary versus secondary, depends entirely on what the physician documents as the underlying cause.

M16.2 vs M16.0: Key differences

The most common coding mistake in the M16 category is using M16.0 when the physician has documented hip dysplasia as the cause of the OA. These two codes look similar at a glance but represent fundamentally different clinical diagnoses.

The key rule: M16.2 applies whenever the note says “due to hip dysplasia,” “secondary to DDH,” or “coxarthrosis from developmental dysplasia.” M16.0 is reserved for cases where no structural cause is identified or documented.

Related codes in the M16 category

The full M16 block covers coxarthrosis across all etiologies and laterality combinations. Coders working in orthopedics or physical therapy should have this table accessible when selecting from the M16 range. The AAPC Codify ICD-10-CM lookup provides searchable access to the full code set.

Practices treating musculoskeletal conditions benefit from physical therapy EMR platforms that surface the full M16 block at the point of documentation. This reduces the chance of defaulting to M16.9 when a more specific code is warranted. The same table matters for sports medicine practice management, where hip OA from structural causes is common in younger patients.

Documentation requirements for M16.2

The most common reason M16.2 claims get denied or queried on audit is incomplete documentation. Practices that build documentation checklists into their intake workflow, similar to a HIPAA compliance checklist, catch missing etiology statements before the claim is submitted.

The clinical record must contain all of the following to support M16.2:

• Bilateral OA confirmed: Explicit statement of osteoarthritis affecting both hips, supported by imaging (X-ray, MRI) showing joint space narrowing, osteophytes, or subchondral sclerosis bilaterally.
• Hip dysplasia documented as etiology: The physician’s note must link the OA to dysplasia. Accepted phrases include: “bilateral hip OA due to DDH,” “coxarthrosis secondary to developmental dysplasia of the hip,” “secondary OA from hip dysplasia.”
• Dysplasia history: Prior diagnoses of DDH (ICD-10 Q65.89 or an M16.2 precursor) or a history of pelvic osteotomy should appear in the chart. Imaging evidence of a shallow acetabulum or abnormal CE angle adds further support.
• Laterality confirmed as bilateral: Both hips must be documented as affected. If only one hip is currently symptomatic despite bilateral structural abnormality, the laterality of current OA drives code selection.
• Physician signature: The treating orthopedist or sports medicine physician must sign the note containing the etiology statement. Coders cannot add or infer the dysplastic cause.

Approximate synonyms and alternate terms

Clinical notes rarely use the exact ICD-10 code descriptor verbatim. Knowing the alternate terms for M16.2 helps coders identify the correct code when scanning physician documentation. All of the following map to ICD-10 Code M16.2:

• Bilateral hip osteoarthritis due to developmental dysplasia of the hip (DDH)
• Coxarthrosis resulting from dysplasia, bilateral
• Secondary bilateral hip OA from hip dysplasia
• Bilateral dysplastic hip arthritis
• Osteoarthritis of both hips caused by congenital hip dysplasia
• Bilateral hip OA secondary to shallow acetabulum / acetabular dysplasia
• Bilateral coxarthrosis from DDH

The term “coxarthrosis” appears frequently in orthopedic literature and WHO documentation as the clinical synonym for osteoarthritis of the hip. For coders working in orthopedic or musculoskeletal settings, recognizing this term is essential when reviewing procedure notes from surgeons trained outside the US.

Related bilateral secondary OA not caused by dysplasia falls under M16.6, so confirming etiology still matters before assigning either code.

CPT codes commonly used with M16.2

M16.2 frequently appears on claims alongside surgical and non-surgical procedure codes. Payer-specific coverage policies determine which pairings are reimbursable. Always verify via the relevant LCD or NCD before submission. The table below reflects commonly associated CPT codes based on AAPC crosswalk data. No specific CPT-to-M16.2 pairing is universally reimbursed without payer verification.

CPT 27130 (total hip arthroplasty) is the highest-volume surgical pairing with M16.2. When billing THA with M16.2, verify the payer’s LCD for medical necessity criteria. Most policies require radiographic documentation of severe narrowing and failed conservative management, such as a structured weight loss workout plan or physical therapy.

CMS coverage policies for hip arthroplasty procedures change annually. Check the current LCD before submission.

Common coding errors and how to avoid them

Three errors account for most M16.2 rejections and audit flags. Coders handling orthopedic claims should run a quick mental checklist against each before submission. Structured chart review at the point of coding also catches M16.9 misuse before submission.

• Using M16.0 when dysplasia is documented: The most frequent error. If the physician’s note mentions DDH, hip dysplasia, or structural etiology for the OA, M16.0 is wrong. M16.2 is the required code.
• Assigning M16.2 without documented etiology: The inverse error. Coders cannot infer hip dysplasia from imaging findings alone. If the note does not explicitly state dysplastic etiology, query the physician or default to M16.0.
• Coding M25.551 instead of M16.2: M25.551 is a symptom code representing hip pain, not a diagnosis. When the underlying diagnosis is confirmed bilateral dysplastic OA, M16.2 is the correct code. M25.551 only applies when OA has not yet been diagnosed and hip pain is the presenting symptom under investigation.
• Missing bilateral specificity: M16.2 requires both hips to be affected. If only one hip has OA despite bilateral structural dysplasia, use M16.31 or M16.32 (unilateral, specifying the side).
• Using M16.9 (unspecified): Unspecified codes should only be used when the chart genuinely lacks the detail to support a specific subcode. When dysplasia is documented bilaterally, using M16.9 is undercoding and may trigger medical necessity reviews.

ICD-9-CM to ICD-10-CM: Historical code mapping

For legacy claim audits, retrospective record reviews, or payer correspondence involving claims filed before October 1, 2015, coders need the approximate ICD-9-CM equivalent. The General Equivalence Mappings (GEMs) crosswalk for ICD-10 Code M16.2 provides an approximate conversion only. GEMs mappings are not always 1:1 and should not be used for active coding decisions.

ICD-9-CM captured secondary etiology under code 715.25, but it did not isolate hip dysplasia as a distinct cause the way ICD-10-CM M16.2 does. Code 715.25 covered any secondary, localized OA of the pelvic region and thigh, not just dysplasia-related cases.

This means historical claims under 715.25 cannot be assumed to represent dysplastic OA specifically. For cross-system audit purposes, treat any 715.25 legacy claim as requiring chart review to confirm the etiology documented at the time. A parallel example is M16.7, which shows how the ICD-10-CM transition improved etiology specificity across the musculoskeletal chapter.

How Pabau streamlines M16.2 documentation and claims

Orthopedic and physical therapy practices that handle high volumes of hip OA claims need their practice management platform to do more than store the code. Most ICD-10 reference pages stop at the code definition without addressing how coding happens inside clinical workflows.

Practice management software like Pabau, with claims management software built in, can link M16.2 at the encounter level to the matching procedure code. That might be 27130 for THA, or a physical therapy code for conservative management.

This pairing check catches mismatched diagnosis-procedure combinations before the claim leaves the practice. Without it, a claim submitted with M16.2 against an incompatible procedure code gets rejected at the payer level.

Pabau’s clinical documentation workflows support ICD-10 code entry at the point of care and tie diagnosis codes to the relevant service line. For practices scaling across multiple orthopedic or MSK specialties, practice management software with native ICD-10 support removes the manual reconciliation step behind coding delays.

Teams evaluating platforms should also assess practice management software features such as code validation, claim scrubbing, and diagnosis-to-procedure linking.

Reduce M16.2 claim denials with built-in coding workflows

Pabau links ICD-10 diagnosis codes directly to procedure codes at claim submission. Flag missing documentation, reduce mismatched pairings, and streamline billing for orthopedic and physical therapy practices.

Book a demo

Conclusion

ICD-10 Code M16.2 is a specific, billable diagnosis for bilateral hip OA caused by hip dysplasia. The single most important rule: the physician must document the dysplastic etiology explicitly. Without that documentation, M16.0 is the correct code, regardless of what imaging shows.

Practices that build documentation checklists into clinical workflows and pair ICD-10 codes with procedure codes at the encounter level see fewer M16.2 denials. Pabau’s claims management software supports this pairing natively. Book a demo to see how it works in an orthopedic or physical therapy billing workflow.

Continue your research

Need to document the exam findings behind a bilateral OA diagnosis? Range of motion assessment covers how to record hip mobility loss consistent with the diagnosis.

Screening older patients for fall risk before hip surgery? Falls efficacy scale gives a validated tool for scoring fear of falling before and after treatment.

Supporting patients through conservative management with nutrition guidance? High-protein meal plan helps patients preserve muscle mass while working toward a healthy weight.

Frequently asked questions